Molina Healthcare, Inc.
MOHNYSEHealthcare● Active
$190.86
$-1.95(-1.01%)
Market Cap$9.9B
P/E Ratio—
52W High$311.52
52W Low$121.06
Molina Healthcare, Inc. (MOH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MOH · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 22, 2026EPS Actual
$2.35
Est. $1.57 · +49.7%
Revenue
$10.80B
Est. $10.87B · -0.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 22, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
MOH reports quarterly as a NYSE-listed Medical - Healthcare Plans company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.84B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.84B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 22, 2026 | $1.45 | — | — | — | $10.84B | — |
| ▲ Q2 FY2026 | Apr 22, 2026 | $1.57 | $2.35 | +49.7% | $10.80B | $10.87B | -0.7% |
| ▼ Q1 FY2026 | Feb 5, 2026 | $0.43 | -$2.75 | -739.5% | $11.38B | $10.88B | +4.6% |
| ▼ Q4 FY2025 | Oct 22, 2025 | $3.97 | $1.84 | -53.6% | $11.48B | $11.29B | +1.7% |
| ▼ Q3 FY2025 | Jul 23, 2025 | $5.62 | $5.48 | -2.5% | $11.43B | $10.95B | +4.3% |
| ▲ Q2 FY2025 | Apr 23, 2025 | $5.97 | $6.08 | +1.8% | $11.15B | $10.84B | +2.8% |
| ▼ Q1 FY2025 | Feb 5, 2025 | $5.74 | $5.05 | -12.0% | $10.50B | $10.28B | +2.1% |
| ▲ Q4 FY2024 | Oct 23, 2024 | $5.81 | $6.01 | +3.4% | $10.34B | $9.91B | +4.3% |
Q3 FY2026
Jul 22, 2026
EPS Actual
—
EPS Est.
$1.45
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 22, 2026Beat
EPS Actual
$2.35
EPS Est.
$1.57
EPS Surpr.
+49.7%
Revenue
$10.80B
Q1 FY2026
Feb 5, 2026Miss
EPS Actual
-$2.75
EPS Est.
$0.43
EPS Surpr.
-739.5%
Revenue
$11.38B
Q4 FY2025
Oct 22, 2025Miss
EPS Actual
$1.84
EPS Est.
$3.97
EPS Surpr.
-53.6%
Revenue
$11.48B
Q3 FY2025
Jul 23, 2025Miss
EPS Actual
$5.48
EPS Est.
$5.62
EPS Surpr.
-2.5%
Revenue
$11.43B
Q2 FY2025
Apr 23, 2025Beat
EPS Actual
$6.08
EPS Est.
$5.97
EPS Surpr.
+1.8%
Revenue
$11.15B
Q1 FY2025
Feb 5, 2025Miss
EPS Actual
$5.05
EPS Est.
$5.74
EPS Surpr.
-12.0%
Revenue
$10.50B
Q4 FY2024
Oct 23, 2024Beat
EPS Actual
$6.01
EPS Est.
$5.81
EPS Surpr.
+3.4%
Revenue
$10.34B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.82 | $1.88 | $1.93 | 2 |
| Q3 FY2028 | $3.10 | $3.21 | $3.29 | 2 |
| Q2 FY2028 | $3.02 | $3.13 | $3.20 | 2 |
| Q1 FY2028 | $3.88 | $4.02 | $4.11 | 2 |
| Q4 FY2027 | $1.35 | $1.40 | $1.43 | 1 |
| Q3 FY2027 | $2.31 | $2.39 | $2.44 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $12.4B | $12.8B | $13.0B | 6 |
| Q3 FY2028 | $12.2B | $12.5B | $12.8B | 3 |
| Q2 FY2028 | $12.0B | $12.4B | $12.6B | 5 |
| Q1 FY2028 | $11.7B | $12.0B | $12.2B | 3 |
| Q4 FY2027 | $11.8B | $12.1B | $12.3B | 7 |
| Q3 FY2027 | $11.6B | $12.0B | $12.2B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 22, 2026 | +49.7% | $151.00 | $153.00 | +1.32% |
| ▼ Q1 FY2026 | Feb 5, 2026 | -739.5% | $178.04 | $176.84 | -0.67% |
| ▼ Q4 FY2025 | Oct 22, 2025 | -53.6% | $196.80 | $195.13 | -0.85% |
| ▼ Q3 FY2025 | Jul 23, 2025 | -2.5% | $180.64 | $190.25 | +5.32% |
| ▲ Q2 FY2025 | Apr 23, 2025 | +1.8% | $321.16 | $332.00 | +3.38% |
| ▼ Q1 FY2025 | Feb 5, 2025 | -12.0% | $315.41 | $317.01 | +0.51% |
| ▲ Q4 FY2024 | Oct 23, 2024 | +3.4% | $283.96 | $275.00 | -3.16% |
| ▲ Q3 FY2024 | Jul 24, 2024 | +6.5% | $286.90 | $288.72 | +0.63% |
Q2 FY2026+1.32%
Report Date
Apr 22, 2026
EPS Beat/Miss
+49.7%
Price Before
$151.00
Price After
$153.00
Q1 FY2026-0.67%
Report Date
Feb 5, 2026
EPS Beat/Miss
-739.5%
Price Before
$178.04
Price After
$176.84
Q4 FY2025-0.85%
Report Date
Oct 22, 2025
EPS Beat/Miss
-53.6%
Price Before
$196.80
Price After
$195.13
Q3 FY2025+5.32%
Report Date
Jul 23, 2025
EPS Beat/Miss
-2.5%
Price Before
$180.64
Price After
$190.25
Q2 FY2025+3.38%
Report Date
Apr 23, 2025
EPS Beat/Miss
+1.8%
Price Before
$321.16
Price After
$332.00
Q1 FY2025+0.51%
Report Date
Feb 5, 2025
EPS Beat/Miss
-12.0%
Price Before
$315.41
Price After
$317.01
Q4 FY2024-3.16%
Report Date
Oct 23, 2024
EPS Beat/Miss
+3.4%
Price Before
$283.96
Price After
$275.00
Q3 FY2024+0.63%
Report Date
Jul 24, 2024
EPS Beat/Miss
+6.5%
Price Before
$286.90
Price After
$288.72
Avg Beat Reaction+0.54%
Avg Miss Reaction+1.08%
Beat Rate4 / 8 quarters
Largest Move+5.32% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MOH ends December
Molina Healthcare, Inc. (MOH) most recently reported earnings on April 22, 2026 for Q2 FY2026, posting EPS of $2.35 — beating the analyst consensus of $1.57 by +49.7%. The next MOH earnings date is expected around September 1, 2026.
Each quarter, investors track MOH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MOH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MOH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MOH earnings · 5 questionsMolina Healthcare, Inc.'s next earnings report is expected around September 1, 2026. MOH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MOH historically reports after market close (AMC).
MOH earnings datewhen is MOH earningsMOH next earnings datewhen does MOH report earningsMOH earnings calendar
▸ Source: FMP · Molina Healthcare, Inc. SEC filings · US GAAP · Molina Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026